Checkpoint Inhibitors: Combination Therapy in Melanoma

http://youtu.be/ptSAnrlo5v0 Keith Flaherty, MD; Jason Luke, MD, FACP; Rene Gonzalez, MD; and Jeffrey Weber, MD, PhD, examine the risks and benefits associated with using ipilimumab in combination with nivolumab in patients with melanoma.